[1]JUNGST C, BERG T, CHENG J, et al.Intrahepatic cholestasis in common chronic liver diseases[J].Eur J Clin Invest, 2013, 43 (10) :1069-1083.
|
[2]KAR SP, SELDIN MF, CHEN W, et al.Pathway-based analysis of primary biliary cirrhosis genome-wide association studies[J].Genes Immun, 2013, 14 (3) :179-186.
|
[3]LEUNG PS, WANG J, NAIYANETR P, et al.Environment and primary biliary cirrhosis:electrophilic drugs and the induction of AMA[J].J Autoimmun, 2013, 41:79-86.
|
[4]IMAM MH, LINDOR KD.The natural history of primary biliary cirrhosis[J].Semin Liver Dis, 2014, 34 (3) :329-333.
|
[5]ZHANG ZY, WANG YP, ZHOU YN.Advances in diagnosis and treatment of primary biliary cholangitis[J].J Clin Hepatol, 2016, 32 (10) :2016-2020. (in Chinese) 张臻英, 王玉平, 周永宁.原发性胆汁性胆管炎诊治进展[J].临床肝胆病杂志, 2016, 32 (10) :2016-2020.
|
[6]DUWAERTS CC, GEHRING S, CHENG CW, et al.Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury[J].Liver Int, 2013, 33 (2) :255-265.
|
[7]ALLER MA, ARIAS JL, PRIETO I, et al.Bile duct ligation:step-by-step to cholangiocyte inflammatory tumorigenesis[J].Eur JGastroenterol Hepatol, 2010, 22 (6) :651-661.
|
[8]WAKABAYASHI K, LIAN ZX, LEUNG PS, et al.Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease[J].Hepatology, 2008, 48 (2) :531-540.
|
[9]FICKERT P, STOGER U, FUCHSBICHLER A, et al.A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis[J].Am J Pathol, 2007, 171 (2) :525-536.
|
[10]OKADA C, AKBAR SM, HORIIKE N, et al.Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I∶Cadministration[J].Liver Int, 2005, 25 (3) :595-603.
|
[11]GUO XX, LI LX, WU YP, et al.Establishment of a mouse model of early primary biliary cirrhosis by polyinosinic-polycytidylic acid[J].J Pract Hepatol, 2014, 17 (6) :619-622. (in Chinese) 郭晓霞, 李良学, 武玉鹏, 等.聚肌胞苷酸诱导的早期原发性胆汁性肝硬化小鼠模型的建立[J].实用肝脏病杂志, 2014, 17 (6) :619-622.
|
[12]SONG G, HU C, ZHU H, et al.Comparative proteomics study on liver mitochondria of primary biliary cirrhosis mouse model[J].BMC Gastroenterol, 2013, 13:64.
|
[13]AMBROSINI YM, YANG GX, ZHANG W, et al.The multi-hit hypothesis of primary biliary cirrhosis:polyinosinic-polycytidylic acid (poly I∶C) and murine autoimmune cholangitis[J].Clin Exp Immunol, 2011, 166 (1) :110-120.
|
[14]PADGETT KA, SELMI C, KENNY TP, et al.Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis[J].J Autoimmun, 2005, 24 (3) :209-219.
|
[15]MATTNER J, SAVAGE PB, LEUNG P, et al.Liver autoimmunity triggered by microbial activation of natural killer T cells[J].Cell Host Microbe, 2008, 3 (5) :304-315.
|
[16]WANG J, SHAN Y, JIANG Z, et al.High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis[J].Clin Exp Immunol, 2013, 174 (2) :212-220.
|
[17]WANG JJ, YANG GX, ZHANG WC, et al.Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD) .B6 (Idd10/Idd18) mice[J].Clin Exp Immunol, 2014, 175 (2) :192-201.
|
[18]BOGDANOS DP, BAUM H, GRASSO A, et al.Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis[J].J Hepatol, 2004, 40 (1) :31-39.
|
[19]XU Y, WANG JB, WANG S, et al.Association between chronic urinary tract infection and primary biliary cirrhosis[J].Chin J Hepatol, 2016, 24 (6) :478-480 (in Chinese) 徐严, 王江滨, 王颂, 等.慢性泌尿系感染与原发性胆汁性肝硬化的关系[J].中华肝脏病杂志, 2016, 24 (6) :478-480.
|
[20]JIANG XH, ZHONG RQ, FANG XY, et al.Establishment of a mouse model of primary biliary cirrhosis by AMA M2 autoantigen injection[J].Chin J Hepatol, 2006, 14 (3) :202-204. (in Chinese) 姜小华, 仲人前, 方晓云, 等.抗线粒体抗体M2抗原诱导小鼠原发性胆汁性肝硬化模型的建立[J].中华肝脏病杂志, 2006, 14 (3) :202-204.
|
[21] BOGDANOS DP, BAUM H, GRASSO A, et al.Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis[J].J Hepatol, 2004, 40 (1) :31-39.
|
[22]YANG GX, LIAN ZX, CHUANG YH, et al.Adoptive transfer of CD8 (+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice[J].Hepatology, 2008, 47 (6) :1974-1982.
|
[23]BERNUZZI F, FENOGLIO D, BATTAGLIA F, et al.Phenotypical and functionalalterations of CD8 regulatory T cells in primary biliary cirrhosis[J].J Autoimmun, 2010, 35 (3) :176-180.
|
[24]FENOGLIO D, BERNUZZI F, BATTAGLIA F, et al.Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases[J].Autoimmun Rev, 2012, 12 (2) :300-304.
|
[25]OERTELT S, LIAN ZX, CHENG CM, et al.Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor IIdominant-negative mice[J].J Immunol, 2006, 177 (3) :1655-1660.
|
[26]KOARADA S, WU Y, CHENG CM, et al.Genetic control of autoimmunity:protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain[J].J Immunol, 2004, 173 (4) :2315-2323.
|
[27]IRIE J, WU Y, WICKER LS, et al.NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis[J].Exp Med, 2006, 203 (5) :1209-1219.
|
[28]KATSUMI T, TOMITA K, LEUNG PS, et al.Animal models of primary biliary cirrhosis[J].Clin Rev Allergy Immunol, 2015, 48 (2-3) :142-153.
|
[29]MORITOKI Y, TSUDA M, TSUNEYAMA K, et al.B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis[J].Cell Immunol, 2011, 268 (1) :16-23.
|
[30]YAO Y, YANG W, YANG YQ, et al.Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha (-/-) mice[J].J Autoimmun, 2014, 51 (4) :99-108.
|
[31]HSU W, ZHANG W, TSUNEYAMA K, et al.Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha (-/-) mice[J].Hepatology, 2009, 49 (1) :133-140.
|
[32]LLEO A, OERTELT-PRIGIONE S, BIANCHI I, et al.Y chromosome loss in male patients with primary biliary cirrhosis[J].JAutoimmun, 2013, 41:87-91.
|
[33]CHEN XM, O'HARA SP, LARUSSO NF, et al.The immunobiology of cholangiocytes[J].Immunol Cell Biol, 2008, 86 (6) :497-505.
|
[34]SALAS JT, BANALES JM, SARVIDE S, et al.Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis[J].Gastroenterology, 2008, 134 (5) :1482-1493.
|
[35]LLEO A, ZHANG W, ZHAO M, et al.DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3promoter in primary biliary cirrhosis[J].Clin Epigenetics, 2015, 7 (1) :61.
|